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Abstract
The patient was a 41 year-old Mexican American women who presented with a decrease in visual
acuity along with periorbital and peripheral edema. She was diagnosed with bilateral serous retinal
detachment and diffuse proliferative lupus nephritis. She improved considerably in hospital after
treatment with corticosteroids.
Case presentation
A 41 year-old Mexican American woman was transferred
from a community hospital emergency department to the
Ophthalmology service of a tertiary care academic
medical center due to progressive, bilateral decrease in
visual acuity over the 2-3 weeks prior to admission. She
was in her usual state of health until two months before
admission when she observed pedal followed by peri-
orbital edema, which increased in severity and was
followed by darkened urine. Her past medical history
was significant for Graves’ disease diagnosed six months
earlier and treated with brief courses of methimazole and
oral prednisone. Methimizole was discontinued by her
primary care provider due to myositis. Prednisone was
self-discontinued by the patient due to concerns regarding
the long-term complications of steroid use.
When the patient’s vision acutely decreased to the point
where she was unable to drive or work, she sought medical
care in her community. She was noted to have spectacle-
corrected visual acuity in the range of 20/200 to 20/400
in both eyes, as well as marked hypertension
(192/115 mmHg). She was treated with labetalol. A
computed tomography (CT) scan was performed that
demonstrated preseptal eyelid edema and mild proptosis
of both eyes. She was transferred with a presumptive
diagnosis of Grave’s orbitopathy requiring urgent orbital
decompression by an oculoplastics specialist. A dose of
intravenous methylprednisolone (1000 mg) was adminis-
tered en route.
Upon arrival, a complete ophthalmologic examination
was performed. The patient noted that in the hours
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following initial administration of intravenous predniso-
lone, her vision had improved. On our examination, best-
corrected visual acuity was 20/100 in each eye. Pupils were
round, reactive, and symmetric with no afferent pupillary
defect. Extraocular movements were full and symmetric;
there was no diplopia in any field of gaze and no evidence
of eyelid retraction. Anterior segment examination
revealed 2+ spongy periorbital edema, 1-2+ white con-
junctival chemosis with no conjunctival injection, and
minimal proptosis clinically. The remainder of the anterior
segment was normal in both eyes. Dilated fundusopic
examination revealed subtle striae in the macula of both
eyes (Figure 1), as well as shallow, non-rhegmetogenous
retinal detachments inferiorly in both eyes with shifting
subretinal fluid. These findings were not consistent with
Graves’ orbitopathy. A repeat CT scan demonstrated mild
bilateral orbital proptosis, minimal enlargement of the
extraocular muscles and no crowding of the optic nerves at
the orbital apex.
Physical examination was also notable for hypertension,
bilateral facial rash, pedal edema and abdominal ascites.
Sensorineural hearing was grossly intact by Weber and
Rinne’s tests. The scalp showed thinned, sparse hair that
she affirmed was unchanged since adolescence.
On review of systems, she had diarrhea for the two weeks
before her admission and mild hearing loss. She also
noted myopathy and pedal paresthesias. She had a 15
pack-year history of tobacco use. Family history was
positive for diabetes mellitus and osteoporosis, but no
kidney, thyroid, or autoimmune disease.
Since the diagnosis of Graves’ orbitopathy appeared in
doubt, additional diagnostic tests were performed.
Laboratory studies were notable for an elevated leukocyte
count of 16.0 K/microliter, and a microcytic anemia with
an hematocrit of 32.7% and a MCV of 79.4 fL. Thyroid
panel revealed normal T3, free T3, and free T4, with a
suppressed TSH (0.03 mIU/L) and positive thyroid
autoantibodies with a TSI of 2.2 (normal <0.3). Her
electrolytes were normal, but the blood urea nitrogen
(BUN) and serum creatinine were 46 mg/dL and 2.0 mg/
dL, respectively. There had been no prior evidence of
impaired kidney function. The Nephrology service was
consulted.
Urinalysis demonstrated proteinuria and hematuria with a
spot protein/creatinine ratio of 7.58. The total serum
cholesterol concentration was 469 mg/dL. Serum albumin
was markedly reduced at 1.3 g/dL. Hepatitis B and C
antibodies were negative. Serum complements were low
(C3 and C4 concentrations 26 and 2.3 mg/dL, respec-
tively). Antinuclear and anti-double stranded DNA anti-
bodies were positive. Anti-glomerular basement
membrane (GBM) antibodies and anti-nuclear cytoplas-
mic antibody (ANCA) studies were negative.
On day three of her hospitalization, the patient underwent
a percutaneous kidney biopsy without complication. The
biopsy demonstrated World Health Organization (WHO)
class IV (diffuse proliferative) lupus nephritis with
endocapillary proliferation, wire loops, cellular crescents,
and karyorrhectic debris. Although the biopsy showed
largely active immune processes, there was evidence of
chronic disease with fibrocellular crescents and segmental
membranoproliferative features with tubular atrophy and
interstitial fibrosis. Electron microscopy demonstrated
hypercellular glomeruli with mesangial and endocapillary
proliferation with infiltrating lymphocytes, neutrophils,
Figure 1. Fundus photograph of the left eye showing macular striae (left panel) and optical cohrerence tomography scan through
the left macula with collections of subretinal fluid (right panel). The photographs were taken on hospital day 4 after several days
of intravenous steroid therapy, at which time the patient’s vision had already significantly improved.
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and macrophages. There were abundant electron dense
deposits in the mesangium and subendothelium with
immunoflorescence evidence of IgG, C3, IgA, IgM, and
C1q (Figure 2). The patient continued on intravenous
corticosteroids. Her best-corrected vision continued to
improve, to 20/40 in both eyes on hospital day four.
Discussion
Ophthalmologic complications of kidney disease in
general and of systemic lupus erythematosus (SLE) in
particular are not uncommon but are rarely threshold
signs for nephrologists to establish the diagnosis of acute
or chronic kidney disease. Despite their vastly different
functions, both organs are vulnerable to similar patho-
logical processes. One can broadly categorize these
complications into genetic, vascular/volume-related,
inflammatory, and systemic/metabolic disease-related
etiologies.
Several genetic diseases have both renal and ophthalmo-
logic manifestations. Alport’s syndrome, an X-linked
recessive and autosomal recessive disease, has sensory
degredations including posterior corneal dystrophy, juve-
nile arcus and retinal pigmentation changes in addition to
hematuria. Cystinosis largely plagues neonates with
kidney failure and corneal dysfunction. Fabry’s disease, a
lysosomal storage disease, presents with kidney failure
and corneal vessel tortuosity and anterior subcapsular
opacities in infants. Oculocerebrorenal syndrome (Lowe’s
syndrome), is characterized by renal tubular acidosis in
conjunction with corneal keloids, glaucoma, and cataracts.
Fluid dynamics play a joint pathophysiological role in
impaired kidney function and associated ophthalmologic
disease, as the interstitial spaces of the eye are subject to
Starling’s principles of fluid dynamics. Fluid will tend to
shift toward the interstitial space if hydrostatic pressure
increases, oncotic pressure decreases (due to reduced
plasma proteins) or if capillary vessels become more
permeable to fluid movement. These conditions tend to be
particularly problematic in the setting of glomerular
disease. Older primate experiments demonstrated that
with highly elevated blood pressures, one would observe
bilateral serous retinal detachments [1]. Notably, any
process that alters the integrity of the glomerular basement
membrane can lead to proteinuria, reduced plasma
protein concentration, and thus a decrease in plasma
oncotic pressure which leads to fluid displacement into
interstitial spaces such as compartments adjacent to the
retina of the eye.
Several systemic diseases contribute to both ocular and
renal pathology. The most notable are the long-term
sequelae of diabetes mellitus in which one sees kidney
damage characterized initially by microalbuminuria fol-
lowed by glomerulosclerosis and ultimately kidney failure;
in the eye, hyperglycemia causes increased glucose to enter
retinal cells and become converted to sorbitol. The excess
sorbitol concentration increases the osmolality within
retinal cells and results in cell swelling, which ultimately
leads to retinal cell dysfunction. Both organ systems are
also highly susceptible to immune complex deposition
and damage that leads to fluid displacements into the
interstitium. As evidence, experimentally induced type III
hypersensitivity reactions in rabbits resulted in bilateral
uveitis and glomerulonephritis in the same animals [2, 3].
Many of the glomerulonephritidies involve systemic
immune-related responses with B-lymphocyte hyperactiv-
ity or autoantibody production. These reactions are best
illustrated in the systemic vasculitidies such as polyarteritis
nodosa and Wegener’s granulomatosis. In the latter,
antibodies against type-IV collagen produce both hema-
turia and ocular inflammatory reactions that result in
keratitis, scleritis, and episcleritis.
Figure 2. Light microscopy, immunoflorescence and electron microscopy of kidney biopsy section taken on hospital day 3
(see text).
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Systemic lupus erythematosus (SLE) is a chronic systemic
autoimmune disease whose pathology affects multiple
organ systems including the eye. Typically, the dis-
ease involves multiple organs including cutaneous,
rheumatologic, renal, cardiac, and neural systems. The
diagnosis can be made if four of eleven diagnostic criteria
are met from the American College of Rheumatology [4].
Kidney disease complicates approximately 50% of docu-
mented SLE; characteristic findings include microscopic
hematuria, proteinuria (often above 3 g/day), hyperten-
sion and impaired kidney function, depending on the
severity, duration and subtype of the disease. The ocular
process most commonly associated with SLE is kerato-
conjunctivitis sicca [5], a dry eye syndrome resulting from
damage in the lacrimal secretory glands. A more concern-
ing ocular finding is scleritis, an inflammation of the sclera
that manifests as intraocular inflammation and choroidal
thickening. Retinal involvement is also common with the
classic findings of cotton-wool spots as well as retinal
vasculitis. Our patient was particularly interesting because
these typical ophthalmic findings were absent, most
notably the vasculitis and evidence of intraocular inflam-
mation. Choroidal involvement is much less common but
has been reported to present with bilateral serous retinal
detachment [5]. The onset of ophthalmic manifestations
of lupus may herald a flare of systemic disease and should
prompt appropriate investigation [6].
The presentation of choroidopathy with SLE follows some
typical epidemiological patterns of SLE; for example, 93%
of patients who presented with choroidopathy and retinal
detachments with SLE occurred in women [7]. Nguyen and
colleagues [7] documented that between 1968 and 1998,
96% of patients were known to have a diagnosis of SLE at
the onset of choroidopathy. The exceptions occurred only
in patients who did not have primary and long-term access
to healthcare; patients then presented to emergency
departments with blurred vision and lupus was subse-
quently diagnosed during the basic work-up, as occurred
here. Our patient was an undocumented resident without
access to primary care except at a local free clinic near her
home. Thus, the stimulus to seek medical care was her
decreased visual acuity, despite observing unusual facial
and pedal edema related to her SLE prior to visual
difficulties.
Several groups who have observed bilateral retinal
detachments in the setting of SLE have noted abnormal-
ities of the retinal pigment epithelium (RPE) [7, 8-10].
Matsuo and colleagues [9] hypothesized that anti-retinal
pigment epithelium antibodies were involved in causing a
dysfunction of the RPE which ultimately led to the
development of serous retinal detachment. Other groups
have observed immune complex deposition in the choroid
withmononuclear infiltrates, whose cytokines might cause
inflammation and fluid collections behind the retina [11].
Other theories have implicated systemic hypertension
typically seen with SLE. Hypertension can cause choroidal
vascular occlusions that would exacerbate edema within
the retina [12]. Our patient demonstrated newly diag-
nosed hypertension related to her underlying kidney
disease. Hypertension, in conjunction with severe hypoal-
buminemia, may have contributed to the fluid accumula-
tion and serous retinal detachments. It is noteworthy that
we saw no evidence of retinal vasculitis on fluorescein
angiography; this test only demonstrated the presence of
subretinal fluid, but no findings consistent with vasculitis
or choroidopathy.
Our patient was referred for presumed ophthalmological
complications of her Graves’ disease. Upon review and
examination, it became clear that the reason for reduced
visual acuity was retinal detachment. She had received
high dose corticosteroids for presumptive treatment of
Graves’ ophthalmopathy. The effect of methylpredniso-
lone on SLE, including the evolving nephritis, may have
helped preserve her vision over the time of her hospital-to-
hospital transfer. Upon discharge from the hospital, the
patient’s vision had improved. Interestingly, Hannouche
and colleagues [8] report resolution of the choroidopathy
after plasmapharesis, which indicates the importance of
immune complex deposition in the pathophysiology of
the disease as well as its management strategy, at least in
some cases.
Conclusion
Here we provide another important example of where
ocular sequelae enlighten the diagnosis and management
of kidney disease. Nephrologists should carefully attend to
the eyes of patients with previous diagnosed SLE who
present to the office or hospital with a flare of the systemic
disease. More generally, choroidopathy should be recog-
nized among the oculorenal syndromes, and considered in
the setting of impaired vision or eye pain associated with
glomerular disease.
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Consent
Patient consent could not be obtained because she was
expeditiously discharged from the hospital and could not
be located, although every effort was undertaken to trace
the patient and her next-of-kin. Every effort has been made
to protect the anonymity of the patient. We believe this
case report contains a worthwhile clinical lesson that could
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not be expressed in any other way. We would not expect
the patient or her next-of-kin to object to publication of
this case report.
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